ArticleCell reports. Medicine2025

Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform.

Yuqing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.